Subscribe to RSS
DOI: 10.1055/a-2771-7640
Navigating Complex Choices in Locally Advanced Rectal Cancer: A Review of Patient Decision-Making, Shared Decision-Making Models, and Future Directions
Authors
Abstract
Decision-making in oncology is uniquely challenging, requiring patients to interpret complex information, weigh uncertain outcomes, and balance survival with quality-of-life considerations. In locally advanced rectal cancer, evolving treatment options such as total neoadjuvant therapy, selective radiation, and nonoperative management via watch-and-wait have made decision-making increasingly nuanced. These choices are preference-sensitive, meaning the optimal approach depends not on a single clinical standard but on the patient's values, goals, and risk tolerance. This review explores how patients navigate key decision points in locally advanced rectal cancer management. We examine individual-level factors that shape decision-making and describe how patients process trade-offs between oncologic risk and functional outcomes. The review also discusses models that support patient decision-making and outlines future directions for research, clinical training, and the development of tools to better understand and meet patients' decisional needs.
Publication History
Article published online:
16 January 2026
© 2026. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Treffers T, Putora PM. Emotions as social information in shared decision-making in oncology. Oncology 2020; 98 (06) 430-437
- 2 Haltaufderheide J, Wäscher S, Bertlich B, Vollmann J, Reinacher-Schick A, Schildmann J. “I need to know what makes somebody tick …”: challenges and strategies of implementing shared decision-making in individualized oncology. Oncologist 2019; 24 (04) 555-562
- 3 Williams CP, Miller-Sonet E, Nipp RD, Kamal AH, Love S, Rocque GB. Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians. Cancer 2020; 126 (15) 3534-3541
- 4 Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns 2006; 60 (03) 301-312
- 5 Abelson JS, Gaetani RS, Hawkins AT. Shared decision making in the treatment of rectal cancer. J Clin Med 2025; 14 (07) 2255
- 6 Liu JB, Moturu A, Temple LKF. et al. Over one-third of surgical patients report inadequate shared decision-making: opportunities for improvement from the ACS NSQIP PROMs project. Ann Surg 2025; 282 (03) 449-459
- 7 Hughes TM, Merath K, Chen Q. et al. Association of shared decision-making on patient-reported health outcomes and healthcare utilization. Am J Surg 2018; 216 (01) 7-12
- 8 Gaetani RS, Ladin K, Abelson JS. Journey through the decades: the evolution in treatment and shared decision making for locally advanced rectal cancer. Cancers (Basel) 2024; 16 (16) 2807
- 9 Fokas E, Allgäuer M, Polat B. et al; German Rectal Cancer Study Group. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. J Clin Oncol 2019; 37 (34) 3212-3222
- 10 Conroy T, Bosset JF, Etienne PL. et al; Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2021; 22 (05) 702-715
- 11 Gani C, Fokas E, Polat B. et al. Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial. Lancet Gastroenterol Hepatol 2025; 10 (06) 562-572
- 12 Kasi A, Abbasi S, Handa S. et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw Open 2020; 3 (12) e2030097
- 13 Garcia-Aguilar J, Patil S, Gollub MJ. et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 2022; 40 (23) 2546-2556
- 14 Benson AB, Venook AP, Al-Hawary MM. et al. Rectal cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2022; 20 (10) 1139-1167
- 15 Langenfeld SJ, Davis BR, Vogel JD. et al; Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of rectal cancer 2023 supplement. Dis Colon Rectum 2024; 67 (01) 18-31
- 16 Habr-Gama A, Perez RO, Nadalin W. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240 (04) 711-717 , discussion 717–718
- 17 Hupkens BJP, Martens MH, Stoot JH. et al. Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection - a matched-controlled study. Dis Colon Rectum 2017; 60 (10) 1032-1040
- 18 Bulens PP, Smets L, Debucquoy A. et al. Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: a prospective cohort study. Clin Transl Radiat Oncol 2022; 36: 113-120
- 19 Custers PA, van der Sande ME, Grotenhuis BA. et al; Dutch Watch-and-Wait Consortium. Long-term quality of life and functional outcome of patients with rectal cancer following a watch-and-wait approach. JAMA Surg 2023; 158 (05) e230146
- 20 Kaul S, Rao C, Mane R. et al. Is the management of rectal cancer using a watch and wait approach feasible, safe and effective in a publicly funded general hospital?. Clin Oncol (R Coll Radiol) 2022; 34 (01) e25-e34
- 21 Rooney MK, De B, Corrigan K. et al. Patient-reported bowel function and bowel-related quality of life after pelvic radiation for rectal adenocarcinoma: the impact of radiation fractionation and surgical resection. Clin Colorectal Cancer 2023; 22 (02) 211-221
- 22 Chiloiro G, Meldolesi E, Giraffa M. et al. Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis. Clin Transl Radiat Oncol 2021; 28: 1-9
- 23 Pascual-Russo A, Milito D, Facio L. et al. Better quality of life and reduced fecal incontinence in rectal cancer patients with the watch-and-wait follow-up strategy. Rev Gastroenterol Mex (Engl Ed) 2021; 86 (04) 340-347
- 24 Quezada-Diaz FF, Smith JJ, Jimenez-Rodriguez RM. et al. Patient-reported bowel function in patients with rectal cancer managed by a watch-and-wait strategy after neoadjuvant therapy: a case-control study. Dis Colon Rectum 2020; 63 (07) 897-902
- 25 van der Valk MJM, Hilling DE, Bastiaannet E. et al; IWWD Consortium. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018; 391 (10139): 2537-2545
- 26 Dattani M, Heald RJ, Goussous G. et al. Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg 2018; 268 (06) 955-967
- 27 Williams H, Fokas E, Diefenhardt M. et al; German Rectal Cancer Study Group, OPRA Consortium. Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials. Ann Oncol 2025; 36 (05) 543-547
- 28 Habr-Gama A, Gama-Rodrigues J, São Julião GP. et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 2014; 88 (04) 822-828
- 29 Keane C, Fearnhead NS, Bordeianou LG. et al; LARS International Collaborative Group. International consensus definition of low anterior resection syndrome. Dis Colon Rectum 2020; 63 (03) 274-284
- 30 Koifman E, Armoni M, Gorelik Y. et al. Long term persistence and risk factors for anorectal symptoms following low anterior resection for rectal cancer. BMC Gastroenterol 2024; 24 (01) 31
- 31 Pieniowski EHA, Palmer GJ, Juul T. et al. Low anterior resection syndrome and quality of life after sphincter-sparing rectal cancer surgery: a long-term longitudinal follow-up. Dis Colon Rectum 2019; 62 (01) 14-20
- 32 Feddern ML, Emmertsen KJ, Laurberg S. Quality of life with or without sphincter preservation for rectal cancer. Colorectal Dis 2019; 21 (09) 1051-1057
- 33 Imaizumi K, Nishizawa Y, Ikeda K, Tsukada Y, Sasaki T, Ito M. Extended pelvic resection for rectal and anal canal tumors is a significant risk factor for perineal wound infection: a retrospective cohort study. Surg Today 2018; 48 (11) 978-985
- 34 Tooley JE, Sceats LA, Bohl DD, Read B, Kin C. Frequency and timing of short-term complications following abdominoperineal resection. J Surg Res 2018; 231: 69-76
- 35 Han JG, Wang ZJ, Qian Q. et al. A prospective multicenter clinical study of extralevator abdominoperineal resection for locally advanced low rectal cancer. Dis Colon Rectum 2014; 57 (12) 1333-1340
- 36 Rencuzogullari A, Abbas MA, Steele S. et al. Predictors of one-year outcomes following the abdominoperineal resection. Am J Surg 2019; 218 (01) 119-124
- 37 Russell MM, Ganz PA, Lopa S. et al. Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04. Ann Surg 2015; 261 (01) 144-148
- 38 Kang SB, Cho JR, Jeong SY. et al; Seoul Colorectal Research Group (SECOG). Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): a long-term prospective, multicentre, cohort study. Lancet Reg Health West Pac 2020; 6: 100087
- 39 How P, Stelzner S, Branagan G. et al. Comparative quality of life in patients following abdominoperineal excision and low anterior resection for low rectal cancer. Dis Colon Rectum 2012; 55 (04) 400-406
- 40 Lee L, Trepanier M, Renaud J. et al. Patients' preferences for sphincter preservation versus abdominoperineal resection for low rectal cancer. Surgery 2021; 169 (03) 623-628
- 41 Konanz J, Herrle F, Weiss C, Post S, Kienle P. Quality of life of patients after low anterior, intersphincteric, and abdominoperineal resection for rectal cancer–a matched-pair analysis. Int J Colorectal Dis 2013; 28 (05) 679-688
- 42 Breugom AJ, van Gijn W, Muller EW. et al. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol 2015; 26 (04) 696-701
- 43 Downing A, Glaser AW, Finan PJ. et al. Functional outcomes and health-related quality of life after curative treatment for rectal cancer: a population-level study in England. Int J Radiat Oncol Biol Phys 2019; 103 (05) 1132-1142
- 44 Bruheim K, Guren MG, Skovlund E. et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010; 76 (04) 1005-1011
- 45 Hardiman KM, Felder SI, Friedman G, Migaly J, Paquette IM, Feingold DL. Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the surveillance and survivorship care of patients after curative treatment of colon and rectal cancer. Dis Colon Rectum 2021; 64 (05) 517-533
- 46 Herman JM, Narang AK, Griffith KA. et al. The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2013; 85 (01) e15-e19
- 47 Ho VP, Lee Y, Stein SL, Temple LK. Sexual function after treatment for rectal cancer: a review. Dis Colon Rectum 2011; 54 (01) 113-125
- 48 Wiltink LM, Chen TY, Nout RA. et al. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. Eur J Cancer 2014; 50 (14) 2390-2398
- 49 Peeters KC, van de Velde CJ, Leer JW. et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients–a Dutch colorectal cancer group study. J Clin Oncol 2005; 23 (25) 6199-6206
- 50 Basch E, Dueck AC, Mitchell SA. et al. Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (alliance N1048). J Clin Oncol 2023; 41 (21) 3724-3734
- 51 Erkaya M, Benlice C, Baca B, Gorgun E. Survival outcomes and pathologic complete response following neoadjuvant chemoradiotherapy versus chemotherapy alone in locally advanced rectal cancer. Surg Oncol 2025; 61: 102252
- 52 Gaetani RS, Russell TA, Kwan KL, Ladin K, Abelson JS. Watch-and-wait for rectal cancer: insights from ASCRS members. Dis Colon Rectum 2025; 68 (10) 1135-1138
- 53 Neshan M, Padmanaban V, Fareed N, Ruff SM, Kelly EP, Pawlik TM. Patient decisional preferences: a systematic review of instruments used to determine patients' preferred role in decision-making. Med Care Res Rev 2025; 82 (03) 225-239
- 54 Noteboom EA, May AM, van der Wall E, de Wit NJ, Helsper CW. Patients' preferred and perceived level of involvement in decision making for cancer treatment: a systematic review. Psychooncology 2021; 30 (10) 1663-1679
- 55 Tariman JD, Berry DL, Cochrane B, Doorenbos A, Schepp K. Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. Ann Oncol 2010; 21 (06) 1145-1151
- 56 Damm K, Vogel A, Prenzler A. Preferences of colorectal cancer patients for treatment and decision-making: a systematic literature review. Eur J Cancer Care (Engl) 2014; 23 (06) 762-772
- 57 Kowal M, Douglas F, Jayne D, Meads D. Patient choice in colorectal cancer treatment - a systematic review and narrative synthesis of attribute-based stated preference studies. Colorectal Dis 2022; 24 (11) 1295-1307
- 58 Schuler M, Schildmann J, Trautmann F. et al. Cancer patients' control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer center. Support Care Cancer 2017; 25 (09) 2753-2760
- 59 Gu XF, Xu HF, Liu Y. et al. Involvement in treatment decision-making and self-reported efficacy among patients with advanced colorectal cancer: a nationwide multi-center cross-sectional study. Front Oncol 2023; 13: 1168078
- 60 Colley A, Halpern J, Paul S. et al. Factors associated with oncology patients' involvement in shared decision making during chemotherapy. Psychooncology 2017; 26 (11) 1972-1979
- 61 Abelson JS, Chait A, Shen MJ, Charlson M, Dickerman A, Yeo HL. Sources of distress among patients undergoing surgery for colorectal cancer: a qualitative study. J Surg Res 2018; 226: 140-149
- 62 Abelson JS, Chait A, Shen MJ, Charlson M, Dickerman A, Yeo H. Coping strategies among colorectal cancer patients undergoing surgery and the role of the surgeon in mitigating distress: a qualitative study. Surgery 2019; 165 (02) 461-468
- 63 Gilligan T, Coyle N, Frankel RM. et al. Patient-clinician communication: American Society of Clinical Oncology Consensus Guideline. J Clin Oncol 2017; 35 (31) 3618-3632
- 64 Carlson LE, Ismaila N, Addington EL. et al. Integrative oncology care of symptoms of anxiety and depression in adults with cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol 2023; 41 (28) 4562-4591
- 65 Andersen BL, Lacchetti C, Ashing K. et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol 2023; 41 (18) 3426-3453
- 66 Crouch A, Von Ah D. The relationship between self-reported cognitive abilities and psychological symptoms in breast cancer survivors. Cancer Nurs 2023; 46 (01) 29-35
- 67 Mayo SJ, Edelstein K, Atenafu EG, Ajaj R, Li M, Bernstein LJ. Cognitive symptoms across diverse cancers. JAMA Netw Open 2024; 7 (08) e2430833
- 68 Fardell JE, Vardy J, Shah JD, Johnston IN. Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology (Berl) 2012; 220 (01) 183-193
- 69 Cruzado JA, López-Santiago S, Martínez-Marín V, José-Moreno G, Custodio AB, Feliu J. Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. Support Care Cancer 2014; 22 (07) 1815-1823
- 70 Lennes IT, Temel JS, Hoedt C, Meilleur A, Lamont EB. Predictors of newly diagnosed cancer patients' understanding of the goals of their care at initiation of chemotherapy. Cancer 2013; 119 (03) 691-699
- 71 Watson R, Bryant J, Sanson-Fisher R, Turon H, Hyde L, Herrmann A. Do haematological cancer patients get the information they need about their cancer and its treatment? Results of a cross-sectional survey. Support Care Cancer 2019; 27 (04) 1509-1517
- 72 Hyatt A, Shelly A, Cox R, Humphries E, Lock G, Varlow M. How can we improve information for people affected by cancer? A national survey exploring gaps in current information provision, and challenges with accessing cancer information online. Patient Educ Couns 2022; 105 (08) 2763-2770
- 73 Coughlin SS, Datta B, Vernon M, Hatzigeorgiou C, George V. Health literacy among cancer survivors: results from the 2016 behavioral risk factor surveillance system survey. Medicine (Baltimore) 2022; 101 (09) e29010
- 74 Kieffer Campbell J. Health literacy in adult oncology: an integrative review. Oncol Nurs Forum 2020; 47 (01) 18-32
- 75 Dumenci L, Matsuyama R, Riddle DL. et al. Measurement of cancer health literacy and identification of patients with limited cancer health literacy. J Health Commun 2014; 19 (02, suppl 2): 205-224
- 76 Holden CE, Wheelwright S, Harle A, Wagland R. The role of health literacy in cancer care: a mixed studies systematic review. PLoS One 2021; 16 (11) e0259815
- 77 Papadakos JK, Hasan SM, Barnsley J. et al. Health literacy and cancer self-management behaviors: a scoping review. Cancer 2018; 124 (21) 4202-4210
- 78 Davis TC, Williams MV, Marin E, Parker RM, Glass J. Health literacy and cancer communication. CA Cancer J Clin 2002; 52 (03) 134-149
- 79 Atherton K, Young B, Kalakonda N, Salmon P. Perspectives of patients with haematological cancer on how clinicians meet their information needs: “managing” information versus “giving” it. Psychooncology 2018; 27 (07) 1719-1726
- 80 Pignatiello GA, Martin RJ, Hickman Jr RL. Decision fatigue: a conceptual analysis. J Health Psychol 2020; 25 (01) 123-135
- 81 Steward G, Looi V, Chib VS. The neurobiology of cognitive fatigue and its influence on effort-based choice. J Neurosci 2025; 45 (24) e1612242025
- 82 Vohs KD, Baumeister RF, Schmeichel BJ, Twenge JM, Nelson NM, Tice DM. Making choices impairs subsequent self-control: a limited-resource account of decision making, self-regulation, and active initiative. J Pers Soc Psychol 2008; 94 (05) 883-898
- 83 Kang SJ, Kim BY, An HJ. Decision fatigue among cancer patients with recurrence: A qualitative study. Eur J Oncol Nurs 2025; 74: 102778
- 84 Huijgens FL. et al. Cancer Patients' Experiences of Burden when Involved in Treatment Decision Making. Med Decis Making 2025; 272989x251334979
- 85 Blinman P, King M, Norman R, Viney R, Stockler MR. Preferences for cancer treatments: an overview of methods and applications in oncology. Ann Oncol 2012; 23 (05) 1104-1110
- 86 Alvarez J, Zambare W, George M. et al. Utilizing patient input in rectal cancer trial design. J Natl Cancer Inst 2025; 117 (07) 1421-1428
- 87 Ciria-Suarez L, Jimenez-Fonseca P, Hernández R, Rogado J, Calderon C. Estimation of risk of recurrence and toxicity among oncologists and patients with resected breast cancer: a quantitative study. Front Psychol 2020; 11: 540083
- 88 Hoesseini A, Dorr MC, Dronkers EAC, de Jong RJB, Sewnaik A, Offerman MPJ. Decisional conflict in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg 2023; 149 (02) 160-167
- 89 Barry MJ, Edgman-Levitan S. Shared decision making–pinnacle of patient-centered care. N Engl J Med 2012; 366 (09) 780-781
- 90 Elwyn G, Frosch D, Thomson R. et al. Shared decision making: a model for clinical practice. J Gen Intern Med 2012; 27 (10) 1361-1367
- 91 Elwyn G, Durand MA, Song J. et al. A three-talk model for shared decision making: multistage consultation process. BMJ 2017; 359: j4891
- 92 Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999; 49 (05) 651-661
- 93 O'Connor A, Stacey D, Jacobsen M. Ottawa Decision Support Framework. 2015 . Accessed June 12, 2025 at: https://decisionaid.ohri.ca/odsf.html
- 94 Quality AHRa. The SHARE Approach: A Model for Shared Decision Making. 2014. Rockville, MD:
- 95 Bomhof-Roordink H, Gärtner FR, Stiggelbout AM, Pieterse AH. Key components of shared decision making models: a systematic review. BMJ Open 2019; 9 (12) e031763
- 96 Stacey D, Samant R, Bennett C. Decision making in oncology: a review of patient decision aids to support patient participation. CA Cancer J Clin 2008; 58 (05) 293-304
- 97 Brown R, Butow P, Wilson-Genderson M, Bernhard J, Ribi K, Juraskova I. Meeting the decision-making preferences of patients with breast cancer in oncology consultations: impact on decision-related outcomes. J Clin Oncol 2012; 30 (08) 857-862
- 98 Austin CA, Mohottige D, Sudore RL, Smith AK, Hanson LC. Tools to promote shared decision making in serious illness: a systematic review. JAMA Intern Med 2015; 175 (07) 1213-1221
- 99 Garcia-Retamero R, Cokely ET. Designing visual aids that promote risk literacy: a systematic review of health research and evidence-based design heuristics. Hum Factors 2017; 59 (04) 582-627
- 100 Stacey D, Lewis KB, Smith M. et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2024; 1 (01) CD001431
- 101 Davidson KW, Mangione CM, Barry MJ. et al; US Preventive Services Task Force. Collaboration and shared decision-making between patients and clinicians in preventive health care decisions and US Preventive Services Task Force Recommendations. JAMA 2022; 327 (12) 1171-1176
- 102 Joseph-Williams N, Williams D, Wood F. et al. A descriptive model of shared decision making derived from routine implementation in clinical practice ('implement-SDM'): qualitative study. Patient Educ Couns 2019; 102 (10) 1774-1785
- 103 van Veenendaal H, Voogdt-Pruis HR, Ubbink DT. et al. Evaluation of a multilevel implementation program for timeout and shared decision making in breast cancer care: a mixed methods study among 11 hospital teams. Patient Educ Couns 2022; 105 (01) 114-127
- 104 Dennison Himmelfarb CR, Beckie TM, Allen LA. et al; American Heart Association Council on Cardiovascular and Stroke Nursing, American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Quality of Care and Outcomes Research; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; Council on Epidemiology and Prevention; and Stroke Council. Shared decision-making and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2023; 148 (11) 912-931
- 105 Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285 (21) 2750-2756
- 106 Forner D, Noel CW, Shuman AG. et al. Shared decision-making in head and neck surgery: a review. JAMA Otolaryngol Head Neck Surg 2020; 146 (09) 839-844
- 107 Kon AA, Davidson JE, Morrison W, Danis M, White DB. Shared decision-making in intensive care units. executive summary of the American College of Critical Care Medicine and American Thoracic Society Policy Statement. Am J Respir Crit Care Med 2016; 193 (12) 1334-1336
- 108 Nizet P, Grivel C, Rabeau P. et al. Patients' preferences in therapeutic decision-making in digestive oncology: a single centre cross-sectional observational study. Sci Rep 2023; 13 (01) 8534
- 109 Becker C, Gross S, Gamp M. et al. Patients' preference for participation in medical decision-making: secondary analysis of the BEDSIDE-OUTSIDE trial. J Gen Intern Med 2023; 38 (05) 1180-1189
- 110 Sandman L, Munthe C. Shared decision making, paternalism and patient choice. Health Care Anal 2010; 18 (01) 60-84
- 111 Wang L, Wang X, Lo A. et al. Effects of radiation and surgery on function and quality of life (QOL) in rectal cancer patients. Am J Surg 2018; 215 (05) 863-866
- 112 Gaedcke J, Sahrhage M, Ebeling M. et al; German Rectal Cancer Study Group. Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial. Sci Rep 2025; 15 (01) 5401
- 113 Epstein RM, Duberstein PR, Fenton JJ. et al. Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncol 2017; 3 (01) 92-100
- 114 Choi S, Choi J. Effects of the teach-back method among cancer patients: a systematic review of the literature. Support Care Cancer 2021; 29 (12) 7259-7268
- 115 Bernacki RE, Block SD. American College of Physicians High Value Care Task Force. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med 2014; 174 (12) 1994-2003
- 116 Forcino RC, Yen RW, Aboumrad M. et al. US-based cross-sectional survey of clinicians' knowledge and attitudes about shared decision-making across healthcare professions and specialties. BMJ Open 2018; 8 (10) e022730
- 117 Berkhof M, van Rijssen HJ, Schellart AJ, Anema JR, van der Beek AJ. Effective training strategies for teaching communication skills to physicians: an overview of systematic reviews. Patient Educ Couns 2011; 84 (02) 152-162
- 118 Singh Ospina N, Toloza FJK, Barrera F, Bylund CL, Erwin PJ, Montori V. Educational programs to teach shared decision making to medical trainees: a systematic review. Patient Educ Couns 2020; 103 (06) 1082-1094
- 119 Hamstra S. et al. Milestones National Report 2019. Accreditation Council for Graduate Medical Education; 2019
- 120 Weintraub L, Figueiredo L, Roth M, Levy A. The feasibility of implementing a communication skills training course in pediatric hematology/oncology fellowship. Pediatr Hematol Oncol 2016; 33 (7–8): 480-490
- 121 Elwyn G, O'Connor AM, Bennett C. et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One 2009; 4 (03) e4705
- 122 Stacey D, Légaré F, Lewis KB. Patient decision aids to engage adults in treatment or screening decisions. JAMA 2017; 318 (07) 657-658
- 123 Coronado-Vázquez V, Canet-Fajas C, Delgado-Marroquín MT, Magallón-Botaya R, Romero-Martín M, Gómez-Salgado J. Interventions to facilitate shared decision-making using decision aids with patients in primary health care: a systematic review. Medicine (Baltimore) 2020; 99 (32) e21389
- 124 Yen RW, Smith J, Engel J. et al. A systematic review and meta-analysis of patient decision aids for socially disadvantaged populations: update from the international patient decision aid standards (IPDAS). Med Decis Making 2021; 41 (07) 870-896
- 125 Poprzeczny AJ, Stocking K, Showell M, Duffy JMN. Patient decision aids to facilitate shared decision making in obstetrics and gynecology: a systematic review and meta-analysis. Obstet Gynecol 2020; 135 (02) 444-451
- 126 Wu RC, Boushey RP, Scheer AS. et al. Evaluation of the rectal cancer patient decision aid: a before and after study. Dis Colon Rectum 2016; 59 (03) 165-172
- 127 Smets L, Debucquoy A, Oldenburger E. et al. Development of a patient decision aid for rectal cancer patients with clinical complete response after neo-adjuvant treatment. Cancers (Basel) 2023; 15 (03) 806
- 128 Stacey D, Volk RJ. IPDAS Evidence Update Leads (Hilary Bekker, Karina Dahl Steffensen, Tammy C. Hoffmann, Kirsten McCaffery, Rachel Thompson, Richard Thomson, Lyndal Trevena, Trudy van der Weijden, and Holly Witteman). Evidence update 2.0. Med Decis Making 2021; 41 (07) 729-733
- 129 Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res 1997; 29 (03) 21-43
- 130 Singh JA, Sloan JA, Atherton PJ. et al. Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the control preferences scale. Am J Manag Care 2010; 16 (09) 688-696
- 131 Kehl KL, Landrum MB, Arora NK. et al. Association of actual and preferred decision roles with patient-reported quality of care: shared decision making in cancer care. JAMA Oncol 2015; 1 (01) 50-58
- 132 O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995; 15 (01) 25-30
- 133 Sim JA, Shin JS, Park SM. et al. Association between information provision and decisional conflict in cancer patients. Ann Oncol 2015; 26 (09) 1974-1980
- 134 Nicolai J, Buchholz A, Seefried N. et al. When do cancer patients regret their treatment decision? A path analysis of the influence of clinicians' communication styles and the match of decision-making styles on decision regret. Patient Educ Couns 2016; 99 (05) 739-746
- 135 Calderon C, Ferrando PJ, Lorenzo-Seva U. et al. Validity and reliability of the decision regret scale in cancer patients receiving adjuvant chemotherapy. J Pain Symptom Manage 2019; 57 (04) 828-834
- 136 Becerra Pérez MM, Menear M, Brehaut JC, Légaré F. Extent and predictors of decision regret about health care decisions: a systematic review. Med Decis Making 2016; 36 (06) 777-790
- 137 Ferron Parayre A, Labrecque M, Rousseau M, Turcotte S, Légaré F. Validation of SURE, a four-item clinical checklist for detecting decisional conflict in patients. Med Decis Making 2014; 34 (01) 54-62
- 138 Roy M, Novak CB, Urbach DR, McCabe SJ, von Schroeder HP, Okrainec K. Decisional conflict in surgical patients: should surgeons care?. Can J Surg 2019; 62 (03) 1-3
- 139 Brehaut JC, O'Connor AM, Wood TJ. et al. Validation of a decision regret scale. Med Decis Making 2003; 23 (04) 281-292
- 140 Brera AS, Arrigoni C, Magon A. et al. A scoping review of decision regret in non-communicable diseases: the emerging roles of patient-clinician communication, psychological aspects, and medical outcomes. Patient Educ Couns 2025; 130: 108478
- 141 Chehade M, Mccarthy MM, Squires A. Patient-related decisional regret: an evolutionary concept analysis. J Clin Nurs 2024; 33 (11) 4484-4503
